X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,335,604 | -43.8% | 14,986,793 | 0.0% | 1.26% | -43.1% |
| Q2 2023 | $29,074,378 | +184.7% | 14,986,793 | +27.7% | 2.22% | +214.3% |
| Q1 2023 | $10,211,010 | -12.4% | 11,736,793 | 0.0% | 0.71% | +7.8% |
| Q4 2022 | $11,654,635 | +4.5% | 11,736,793 | +79.9% | 0.66% | +17.6% |
| Q3 2022 | $11,155,000 | +234.7% | 6,523,157 | +1856.9% | 0.56% | +220.1% |
| Q1 2020 | $3,333,000 | -6.6% | 333,333 | 0.0% | 0.17% | +3.0% |
| Q4 2019 | $3,567,000 | -15.8% | 333,333 | 0.0% | 0.17% | -51.9% |
| Q3 2019 | $4,237,000 | -15.3% | 333,333 | 0.0% | 0.35% | +0.3% |
| Q2 2019 | $5,000,000 | -13.8% | 333,333 | 0.0% | 0.35% | +16.3% |
| Q1 2019 | $5,803,000 | – | 333,333 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,109,000 | 3.48% |
| SV Health Investors, LLC | 311,490 | $2,109,000 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,648,485 | $11,160,000 | 1.04% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,268,000 | 0.91% |
| Ikarian Capital, LLC | 724,680 | $4,907,000 | 0.36% |
| BVF INC/IL | 792,892 | $5,368,000 | 0.29% |
| Opaleye Management Inc. | 75,000 | $508,000 | 0.10% |
| Orbimed Advisors | 1,086,493 | $7,356,000 | 0.09% |
| RA Capital Management | 559,494 | $3,788,000 | 0.07% |
| Bleichroeder LP | 35,730 | $242,000 | 0.04% |